Literature DB >> 33782268

Relationship of Body Mass Index With Fuchs Endothelial Corneal Dystrophy Severity and TCF4 CTG18.1 Trinucleotide Repeat Expansion.

Bhumi B Kinariwala1, Timothy T Xu2, Keith H Baratz3, Ross A Aleff4, Sanjay V Patel3, Leo J Maguire3, Michael P Fautsch3, Eric D Wieben4, Amy E Millen5, Sangita P Patel1,6.   

Abstract

PURPOSE: To investigate the association of body mass index (BMI) with Fuchs endothelial corneal dystrophy (FECD) severity and TCF4 CTG18.1 expansion.
METHODS: A total of 343 patients with FECD were enrolled from the Mayo Clinic. FECD severity was graded by slit-lamp biomicroscopy. BMI values were obtained from the electronic medical records. DNA extracted from leukocytes was analyzed for CTG18.1 expansion length, with ≥40 repeats considered expanded. Wilcoxon signed-rank tests were used to compare FECD grade and CTG18.1 expansion length in patients by BMI (<25, ≥25 to <30, and ≥30 kg/m2). FECD grade was regressed on age, sex, BMI, and CTG18.1 expansion and, separately, BMI on CTG18.1 expansion. Models were investigated for effect modification by age and sex with an interaction term of P < 0.05 considered statistically significant.
RESULTS: When examining the association between BMI and FECD, there was a significant interaction between BMI and sex (P for interaction = 0.004). When controlling for age and CTG18.1 expansion, a positive association was observed between BMI and FECD grade in women, but not in men. In addition, BMI was not associated with CTG18.1 expansion when controlling for age and sex.
CONCLUSIONS: BMI was positively associated with FECD severity among women but not men. There was no significant association between BMI and CTG18.1 expansion. These findings suggest that increased BMI is potentially a modifiable risk factor for FECD disease progression among women.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33782268      PMCID: PMC8478960          DOI: 10.1097/ICO.0000000000002689

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   3.152


  11 in total

1.  Association of smoking and other risk factors with Fuchs' endothelial corneal dystrophy severity and corneal thickness.

Authors:  Xiaolin Zhang; Robert P Igo; Jeremy Fondran; V Vinod Mootha; Matt Oliva; Kristin Hammersmith; Alan Sugar; Jonathan H Lass; Sudha K Iyengar
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-27       Impact factor: 4.799

2.  Repeat length variations in polyglutamine disease-associated genes affect body mass index.

Authors:  Sarah L Gardiner; Renée de Mutsert; Stella Trompet; Merel W Boogaard; Ko Willems van Dijk; P J Wouter Jukema; P Eline Slagboom; Raymund A C Roos; Hanno Pijl; Frits R Rosendaal; N Ahmad Aziz
Journal:  Int J Obes (Lond)       Date:  2018-08-17       Impact factor: 5.095

3.  Prevalence of and risk factors for cornea guttata in a population-based study in a southwestern island of Japan: the Kumejima study.

Authors:  Akiko Higa; Hiroshi Sakai; Shoichi Sawaguchi; Aiko Iwase; Atsuo Tomidokoro; Shiro Amano; Makoto Araie
Journal:  Arch Ophthalmol       Date:  2011-03

4.  Body mass index is inversely correlated with the expanded CAG repeat length in SCA3/MJD patients.

Authors:  Jonas Alex Morales Saute; Andrew Chaves Feitosa da Silva; Gabriele Nunes Souza; Aline Dutra Russo; Karina Carvalho Donis; Leonardo Vedolin; Maria Luiza Saraiva-Pereira; Luis Valmor Cruz Portela; Laura Bannach Jardim
Journal:  Cerebellum       Date:  2012-09       Impact factor: 3.847

5.  Prevalence and risk factors for cornea guttata in the Reykjavik Eye Study.

Authors:  Gunnar M Zoega; Aya Fujisawa; Hiroshi Sasaki; Akiko Kubota; Kazuyuki Sasaki; Kazuko Kitagawa; Fridbert Jonasson
Journal:  Ophthalmology       Date:  2006-04       Impact factor: 12.079

6.  Prevalence of primary cornea guttata and morphology of corneal endothelium in aging Japanese and Singaporean subjects.

Authors:  Kitagawa Kitagawa; Masami Kojima; Huroshi Sasaki; Ying-Bo Shui; Sek Jin Chew; Hong-Ming Cheng; Masaji Ono; Yuko Morikawa; Kazuyuki Sasaki
Journal:  Ophthalmic Res       Date:  2002 May-Jun       Impact factor: 2.892

7.  Fuchs' endothelial corneal dystrophy: subjective grading versus objective grading based on the central-to-peripheral thickness ratio.

Authors:  Daniel J Repp; David O Hodge; Keith H Baratz; Jay W McLaren; Sanjay V Patel
Journal:  Ophthalmology       Date:  2013-01-28       Impact factor: 12.079

8.  Association Between Body Mass Index and Disease Severity in Chinese Spinocerebellar Ataxia Type 3 Patients.

Authors:  Jin-Shan Yang; Ping-Ping Chen; Min-Ting Lin; Mei-Zhen Qian; Hui-Xia Lin; Xiao-Ping Chen; Xian-Jin Shang; Dan-Ni Wang; Yu-Chao Chen; Bin Jiang; Yi-Jun Chen; Ning Wang; Wan-Jin Chen; Shi-Rui Gan
Journal:  Cerebellum       Date:  2018-08       Impact factor: 3.847

9.  Body Mass Index Decline Is Related to Spinocerebellar Ataxia Disease Progression.

Authors:  Alhassane Diallo; Heike Jacobi; Tanja Schmitz-Hübsch; Arron Cook; Robyn Labrum; Alexandra Durr; Alexis Brice; Perrine Charles; Cecilia Marelli; Caterina Mariotti; Lorenzo Nanetti; Marta Panzeri; Maria Rakowicz; Anna Sobanska; Anna Sulek; Ludger Schöls; Holger Hengel; Bela Melegh; Alessandro Filla; Antonella Antenora; Jon Infante; José Berciano; Bart P van de Warrenburg; Dagmar Timmann; Sylvia Boesch; Massimo Pandolfo; Jörg B Schulz; Peter Bauer; Paola Giunti; Laszlo Baliko; Michael H Parkinson; Jun-Suk Kang; Thomas Klockgether; Sophie Tezenas du Montcel
Journal:  Mov Disord Clin Pract       Date:  2017-08-11

10.  A common trinucleotide repeat expansion within the transcription factor 4 (TCF4, E2-2) gene predicts Fuchs corneal dystrophy.

Authors:  Eric D Wieben; Ross A Aleff; Nirubol Tosakulwong; Malinda L Butz; W Edward Highsmith; Albert O Edwards; Keith H Baratz
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

View more
  1 in total

1.  Cancer Risk in Patients With Fuchs Endothelial Corneal Dystrophy.

Authors:  Timothy T Xu; Keith H Baratz; Michael P Fautsch; David O Hodge; Michael A Mahr
Journal:  Cornea       Date:  2021-09-27       Impact factor: 3.152

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.